Search Results
FAI 10mg 10mg | Purity Not Available
Adooq Bioscience
CVT 6883 5mg 5mg | Purity Not Available
Adooq Bioscience
CVT-6883, a selective A2B adenosine antagonist, represents a novel potential approach to treating cardiopulmonary diseases.
More Information Supplier PageCVT 6883 25mg 25mg | Purity Not Available
Adooq Bioscience
CVT-6883, a selective A2B adenosine antagonist, represents a novel potential approach to treating cardiopulmonary diseases.
More Information Supplier PageCVT 6883 10mg 10mg | Purity Not Available
Adooq Bioscience
CVT-6883, a selective A2B adenosine antagonist, represents a novel potential approach to treating cardiopulmonary diseases.
More Information Supplier PageCEP-28122 5mg 5mg | Purity Not Available
Adooq Bioscience
CEP-28122 is a highly potent and selective orally active inhibitor of anaplastic lymphoma kinase with antitumor activity in experimental models of human cancers.
More Information Supplier PageCEP-28122 25mg 25mg | Purity Not Available
Adooq Bioscience
CEP-28122 is a highly potent and selective orally active inhibitor of anaplastic lymphoma kinase with antitumor activity in experimental models of human cancers.
More Information Supplier PageEprosartan mesylate 10mM * 1mL in DMSO 10mM * 1mL in DMSO | Purity Not Available
Adooq Bioscience
Eprosartan (mesylate) is a competitive AT1 receptor antagonist with IC50 values ranging from 1.4 ?€? 3.9 nM and an elimination half-life of five to seven hours.
More Information Supplier PageEprosartan mesylate 250mg 250mg | Purity Not Available
Adooq Bioscience
Eprosartan (mesylate) is a competitive AT1 receptor antagonist with IC50 values ranging from 1.4 ?€? 3.9 nM and an elimination half-life of five to seven hours.
More Information Supplier PageMS436 5mg 5mg | Purity Not Available
Adooq Bioscience
MS436 is a diazobenzene-based small-molecule inhibitor for the BRD4 bromodomains with a Ki value of 30-50 nM.
More Information Supplier Page